1. Biochemistry and Chemical Biology

Conformational regulation and target-myristoyl switch of calcineurin B homologous protein 3

  1. Florian Becker
  2. Simon Fuchs
  3. Lukas Refisch
  4. Friedel Drepper
  5. Wolfgang Bildl
  6. Uwe Schulte
  7. Shuo Liang
  8. Jonas Immanuel Heinicke
  9. Sierra C Hansen
  10. Clemens Kreutz
  11. Bettina Warscheid
  12. Bernd Fakler
  13. Evgeny V Mymrikov  Is a corresponding author
  14. Carola Hunte  Is a corresponding author
  1. University of Freiburg, Germany
https://doi.org/10.7554/eLife.83868
Share this article
Cite this article
  1. Florian Becker
  2. Simon Fuchs
  3. Lukas Refisch
  4. Friedel Drepper
  5. Wolfgang Bildl
  6. Uwe Schulte
  7. Shuo Liang
  8. Jonas Immanuel Heinicke
  9. Sierra C Hansen
  10. Clemens Kreutz
  11. Bettina Warscheid
  12. Bernd Fakler
  13. Evgeny V Mymrikov
  14. Carola Hunte
(2023)
Conformational regulation and target-myristoyl switch of calcineurin B homologous protein 3
eLife 12:e83868.
https://doi.org/10.7554/eLife.83868
  2. Download BibTeX
  3. Download .RIS

Abstract

Calcineurin B homologous protein 3 (CHP3) is an EF-hand Ca2+-binding protein involved in regulation of cancerogenesis, cardiac hypertrophy and neuronal development through interactions with sodium/proton exchangers (NHEs) and signalling proteins. While the importance of Ca2+ binding and myristoylation for CHP3 function has been recognized, the underlying molecular mechanism remained elusive. In this study, we demonstrate that Ca2+ binding and myristoylation independently affect the conformation and functions of human CHP3. Ca2+ binding increased local flexibility and hydrophobicity of CHP3 indicative of an open conformation. The Ca2+-bound CHP3 exhibited a higher affinity for NHE1 and associated stronger with lipid membranes compared to the Mg2+-bound CHP3, which adopted a closed conformation. Myristoylation enhanced the local flexibility of CHP3 and decreased its affinity to NHE1 independently of the bound ion, but did not affect its binding to lipid membranes. The data exclude the proposed Ca2+-myristoyl switch for CHP3. Instead, a Ca2+-independent exposure of the myristoyl moiety is induced by binding of the target peptide to CHP3 enhancing its association to lipid membranes. We name this novel regulatory mechanism 'target-myristoyl switch'. Collectively, the interplay of Ca2+ binding, myristoylation, and target binding allows for a context-specific regulation of CHP3 functions.

Data availability

All data generated or analyzed during this study are included in the manuscript. Source files have been provided for Figures 1, 4, 6, and Figure 4-figure supplement 1. Data2Dynamics Software used for EC50 and KD determination is available at GitHub (https://github.com/Data2Dynamics/d2d).

Article and author information

Author details

  1. Florian Becker

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5889-8728

  2. Simon Fuchs

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.

  3. Lukas Refisch

    Institute of Medical Biometry and Statistics, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9049-1944

  4. Friedel Drepper

    Institute of Biology II, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2043-5795

  5. Wolfgang Bildl

    Institute of Physiology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.

  6. Uwe Schulte

    Institute of Physiology, University of Freiburg, Freiburg, Germany
    Competing interests
    Uwe Schulte, is an employee and shareholder of Logopharm GmbH that produces ComplexioLyte 47 used in this study..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3557-0591

  7. Shuo Liang

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.

  8. Jonas Immanuel Heinicke

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.

  9. Sierra C Hansen

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.

  10. Clemens Kreutz

    Institute of Medical Biometry and Statistics, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.

  11. Bettina Warscheid

    Institute of Biology II, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5096-1975

  12. Bernd Fakler

    Institute of Physiology, University of Freiburg, Freiburg, Germany
    Competing interests
    Bernd Fakler, is shareholder of Logopharm GmbH. The company provides ComplexioLyte reagents to academic institutions on a non-profit basis..

  13. Evgeny V Mymrikov

    Institute of Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    For correspondence
    evgeny.mymrikov@biochemie.uni-freiburg.de
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4817-6278

  14. Carola Hunte

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    For correspondence
    carola.hunte@biochemie.uni-freiburg.de
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0826-3986

Funding

Deutsche Forschungsgemeinschaft (EXC-2189 - 390939984)

  • Clemens Kreutz
  • Bettina Warscheid
  • Bernd Fakler
  • Evgeny V Mymrikov
  • Carola Hunte

Deutsche Forschungsgemeinschaft (SFB 1381 - 403222702)

  • Uwe Schulte
  • Bettina Warscheid
  • Carola Hunte

Deutsche Forschungsgemeinschaft (SFB 1453 - 431984000)

  • Bernd Fakler
  • Carola Hunte

Deutsche Forschungsgemeinschaft (RTG 2202 - 278002225)

  • Carola Hunte

Bundesministerium für Bildung und Forschung (FKZ031L0080)

  • Clemens Kreutz

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. M Joanne Lemieux, University of Alberta, Canada

Version history

  1. Preprint posted: September 23, 2022 (view preprint)
  2. Received: September 30, 2022
  3. Accepted: July 3, 2023
  4. Accepted Manuscript published: July 12, 2023 (version 1)
  5. Version of Record published: July 25, 2023 (version 2)

Copyright

© 2023, Becker et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 342
    Page views
  • 50
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Florian Becker
  2. Simon Fuchs
  3. Lukas Refisch
  4. Friedel Drepper
  5. Wolfgang Bildl
  6. Uwe Schulte
  7. Shuo Liang
  8. Jonas Immanuel Heinicke
  9. Sierra C Hansen
  10. Clemens Kreutz
  11. Bettina Warscheid
  12. Bernd Fakler
  13. Evgeny V Mymrikov
  14. Carola Hunte
(2023)
Conformational regulation and target-myristoyl switch of calcineurin B homologous protein 3
eLife 12:e83868.
https://doi.org/10.7554/eLife.83868

Categories and tags

Research organism

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology

    Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications

    Riham Ayoubi, Joel Ryan ... Carl Laflamme
    Research Advance

    Antibodies are critical reagents to detect and characterize proteins. It is commonly understood that many commercial antibodies do not recognize their intended targets, but information on the scope of the problem remains largely anecdotal, and as such, feasibility of the goal of at least one potent and specific antibody targeting each protein in a proteome cannot be assessed. Focusing on antibodies for human proteins, we have scaled a standardized characterization approach using parental and knockout cell lines (Laflamme et al., 2019) to assess the performance of 614 commercial antibodies for 65 neuroscience-related proteins. Side-by-side comparisons of all antibodies against each target, obtained from multiple commercial partners, have demonstrated that: (i) more than 50% of all antibodies failed in one or more applications, (ii) yet, ~50–75% of the protein set was covered by at least one high-performing antibody, depending on application, suggesting that coverage of human proteins by commercial antibodies is significant; and (iii) recombinant antibodies performed better than monoclonal or polyclonal antibodies. The hundreds of underperforming antibodies identified in this study were found to have been used in a large number of published articles, which should raise alarm. Encouragingly, more than half of the underperforming commercial antibodies were reassessed by the manufacturers, and many had alterations to their recommended usage or were removed from the market. This first study helps demonstrate the scale of the antibody specificity problem but also suggests an efficient strategy toward achieving coverage of the human proteome; mine the existing commercial antibody repertoire, and use the data to focus new renewable antibody generation efforts.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease

    Indole produced during dysbiosis mediates host-microorganism chemical communication

    Rui-Qiu Yang, Yong-Hong Chen ... Cheng-Gang Zou
    Research Article

    An imbalance of the gut microbiota, termed dysbiosis, has a substantial impact on host physiology. However, the mechanism by which host deals with gut dysbiosis to maintain fitness remains largely unknown. In Caenorhabditis elegans, Escherichia coli, which is its bacterial diet, proliferates in its intestinal lumen during aging. Here, we demonstrate that progressive intestinal proliferation of E. coli activates the transcription factor DAF-16, which is required for maintenance of longevity and organismal fitness in worms with age. DAF-16 up-regulates two lysozymes lys-7 and lys-8, thus limiting the bacterial accumulation in the gut of worms during aging. During dysbiosis, the levels of indole produced by E. coli are increased in worms. Indole is involved in the activation of DAF-16 by TRPA-1 in neurons of worms. Our finding demonstrates that indole functions as a microbial signal of gut dysbiosis to promote fitness of the host.

    1. Biochemistry and Chemical Biology

    Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2

    Kehan Chen, Lie Wang ... Gang Wu
    Research Article

    Six transmembrane epithelial antigen of the prostate (STEAP) 1–4 are membrane-embedded hemoproteins that chelate a heme prosthetic group in a transmembrane domain (TMD). STEAP2–4, but not STEAP1, have an intracellular oxidoreductase domain (OxRD) and can mediate cross-membrane electron transfer from NADPH via FAD and heme. However, it is unknown whether STEAP1 can establish a physiologically relevant electron transfer chain. Here, we show that STEAP1 can be reduced by reduced FAD or soluble cytochrome b5 reductase that serves as a surrogate OxRD, providing the first evidence that STEAP1 can support a cross-membrane electron transfer chain. It is not clear whether FAD, which relays electrons from NADPH in OxRD to heme in TMD, remains constantly bound to the STEAPs. We found that FAD reduced by STEAP2 can be utilized by STEAP1, suggesting that FAD is diffusible rather than staying bound to STEAP2. We determined the structure of human STEAP2 in complex with NADP+ and FAD to an overall resolution of 3.2 Å by cryo-electron microscopy and found that the two cofactors bind STEAP2 similarly as in STEAP4, suggesting that a diffusible FAD is a general feature of the electron transfer mechanism in the STEAPs. We also demonstrated that STEAP2 reduces ferric nitrilotriacetic acid (Fe3+-NTA) significantly slower than STEAP1 and proposed that the slower reduction is due to the poor Fe3+-NTA binding to the highly flexible extracellular region in STEAP2. These results establish a solid foundation for understanding the function and mechanisms of the STEAPs.